After finishing at $2.39 in the prior trading day, Adicet Bio Inc (NASDAQ: ACET) closed at $2.33, down -2.51%. In other words, the price has decreased by -$0.0600 from its previous closing price. On the day, 1021757 shares were traded.
Ratios:
Our goal is to gain a better understanding of ACET by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 9.40 and its Current Ratio is at 9.40. In the meantime, Its Debt-to-Equity ratio is 0.11 whereas as Long-Term Debt/Eq ratio is at 0.10.
JP Morgan Downgraded its Overweight to Neutral on June 01, 2023, whereas the target price for the stock was revised from $20 to $6.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 25 when ORBIMED ADVISORS LLC bought 3,125,000 shares for $2.40 per share. The transaction valued at 7,500,000 led to the insider holds 7,526,359 shares of the business.
GORDON CARL L bought 3,125,000 shares of ACET for $7,500,000 on Jan 25. The Director now owns 7,526,359 shares after completing the transaction at $2.40 per share. On Oct 02, another insider, Schor Chen, who serves as the President & CEO of the company, bought 5,500 shares for $1.33 each. As a result, the insider paid 7,340 and bolstered with 43,469 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ACET now has a Market Capitalization of 191.18M and an Enterprise Value of 29.72M. Its current Enterprise Value per Revenue stands at 2.14 whereas that against EBITDA is -0.22.
Stock Price History:
Over the past 52 weeks, ACET has reached a high of $8.15, while it has fallen to a 52-week low of $1.10. The 50-Day Moving Average of the stock is 2.5205, while the 200-Day Moving Average is calculated to be 2.5657.
Shares Statistics:
The stock has traded on average 1.45M shares per day over the past 3-months and 1.65M shares per day over the last 10 days, according to various share statistics. A total of 82.05M shares are outstanding, with a floating share count of 65.19M. Insiders hold about 20.55% of the company’s shares, while institutions hold 39.91% stake in the company. Shares short for ACET as of Feb 15, 2024 were 4.75M with a Short Ratio of 3.28, compared to 3.21M on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 5.79% and a Short% of Float of 6.71%.
Earnings Estimates
Its stock is currently analyzed by 8 different market analysts. On average, analysts expect EPS of -$0.69 for the current quarter, with a high estimate of -$0.45 and a low estimate of -$0.78, while EPS last year was -$0.72. The consensus estimate for the next quarter is -$0.58, with high estimates of -$0.28 and low estimates of -$0.78.
Analysts are recommending an EPS of between -$3.09 and -$3.41 for the fiscal current year, implying an average EPS of -$3.32. EPS for the following year is -$2.44, with 8 analysts recommending between -$1.13 and -$3.44.
